Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer.
Year: 2003
Type: article
Abstract: For this study, the researchers used criteria developed by the Office of Cancer Complementary and Alternative Medicine (OCCAM), a part of the National Cancer Institute.
Source: PubMed Central
Authors: P Shekelle, I Coulter, M L Hardy, S C Morton, J T Favreau, J Gagne, S A Coulter, J Udani, E A Roth, L K Jungvig, S Newberry, L Rohr, L R Ramirez
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1493750497